卡尔瓦克罗尔通过降低粉样β积累和调节卵巢切除的血管高血压大鼠的神经炎症来改善认知功能障碍
Duygu Bayraktar1, Büşra Ertaş2, Yasemin Aydın3
1Department of Physiology, Faculty of Medicine, Eskisehir Osmangazi University, Eskisehir, Turkey.
Naunyn-Schmiedeberg's archives of pharmacology
|September 16, 2024
概括
卡尔瓦克罗尔 (CAR) 治疗在绝经后高血压的老鼠模型中改善了学习和记忆. 汽车降低了血压和脑损伤的关键标志物,这表明对记忆障碍的潜在益处.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 心血管研究研究心血管研究
背景情况:
- 高血压会加剧脑损伤和经更年期妇女的认知衰退.
- 卡瓦克罗尔 (CAR) 是一种穿越血脑屏障的化合物,具有抗氧化,抗炎和抗丧的特性.
- 绝经后高血压是认知功能障碍的重要危险因素.
研究的目的:
- 为了研究Carvacrol (CAR) 在绝经后高血压的老鼠模型中的神经保护作用.
- 评估CAR对因卵巢切除和血管高血压引起的学习和记忆缺陷的影响.
- 评估CAR对与认知障碍相关的神经化学变化的影响.
主要方法:
- 在大鼠中通过卵巢切除和两,一剪切手术建立了绝经后高血压的实验模型.
- 卡尔瓦克罗尔 (CAR) 每天给高血压大鼠服用7周.
- 用行为测试评估认知功能,测量血清,皮质和海马体中的神经化学标志物.
主要成果:
- 在高血压大鼠中,CAR治疗显著降低了缩血压.
- 卡尔管理在学习和记忆测试中提高了表现,由增加的识别指数和平台探索表明.
- 汽车降低了粉样β,骨质,IL-6,TNF-α和乙胆酶活性水平,同时在大脑中增加了 neprilysin 和 IL-10.
结论:
- 卡尔瓦克罗尔 (CAR) 在绝经后高血压大鼠模型中显示出对认知障碍的显著神经保护作用.
- CAR抑制粉样β沉积和神经炎症的能力表明它的治疗潜力.
- 在患有高血压的绝经后妇女中,CAR可能提供一种保护性策略,防止记忆障碍.
相关概念视频
01:25Antihypertensive Drugs: Direct Renin Inhibitors
510
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
510
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
398
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
398
01:18Hypertension and Regulation of Blood Pressure
1.9K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
1.9K
01:17Hormonal Regulation of Blood Pressure
2.5K
Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
2.5K
01:23Antihypertensive Drugs: Vasodilators
491
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
491
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
606
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
606